JST

stUSDT 2023 Year in Review

Retrieved on: 
Tuesday, January 30, 2024
TRON, Decentralized finance, JST, USDT, Ecosystem, APY, TVL, TUSD, RWA, Growth, Cryptocurrency

On July 3, 2023, the TRON ecosystem welcomed its first Real-World Asset (RWA) product, stUSDT, which is operated by the decentralized financial platform JustLend DAO.

Key Points: 
  • On July 3, 2023, the TRON ecosystem welcomed its first Real-World Asset (RWA) product, stUSDT, which is operated by the decentralized financial platform JustLend DAO.
  • The stUSDT platform is dedicated to narrowing the divide between retail and institutional investors while connecting the crypto realm with the real world.
  • While a holder’s stUSDT balance increases as it receives daily rebase rewards, wstUSDT accrues the underlying stUSDT rewards and will constantly increase in value beyond 1 stUSDT.
  • On July 14, the stUSDT platform officially launched wstUSDT (wrapped stUSDT), a non-rebasing version of stUSDT.

Sosei Heptares Webinar Presentation for FY2023 Financial Results

Retrieved on: 
Monday, January 22, 2024
CFO, Q&A, JST, GMT

Tokyo, Japan and Cambridge, UK, 22 January 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) will announce its earnings results and present operational highlights for the 12 months ended 31 December 2023 on Tuesday, 13 February 2024.

Key Points: 
  • Tokyo, Japan and Cambridge, UK, 22 January 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) will announce its earnings results and present operational highlights for the 12 months ended 31 December 2023 on Tuesday, 13 February 2024.
  • The Company will host a live webinar presentation with Chris Cargill, President and CEO, Hironoshin Nomura, CFO, Matt Barnes, Head of UK R&D and Satoshi Tanaka, Executive Officer and Executive Vice President of Sosei Heptares and President of Idorsia Pharmaceuticals Japan at 5 pm JST (8 am GMT) on Tuesday, 13 February 2024.
  • The webinar is open to all existing and potential investors as well as sell-/buy-side analysts and will consist of a presentation followed by a Q&A session.
  • Please click here to pre-register, which will provide a link to access the webinar.

JST Digital Announces Strong 2023 Growth & Corporate Update

Retrieved on: 
Thursday, January 18, 2024
Bitcoin, Decentralized finance, JST, Ecosystem, Digital, Investment, Calendar, News, Growth, Cryptocurrency

JST Digital saw significant growth in 2023 and added staff across trading, sales, operations, and technology and expects continued growth in 2024.

Key Points: 
  • JST Digital saw significant growth in 2023 and added staff across trading, sales, operations, and technology and expects continued growth in 2024.
  • SUMMIT, N.J. and SINGAPORE, Jan. 18, 2024 /PRNewswire/ -- JST Digital ("the Company" or "JST"), a global financial services firm specializing in digital assets, today announced its growth metrics, which included a 230% increase in its number of market making clients, alongside corporate updates for 2023.
  • JST Digital experienced a steady increase in trading over the 2023 calendar year on both centralized exchanges and dApps, nearly tripling its list of onboarded clients during that period.
  • Leveraging the firm's deep experience in on-chain trading and technology, in 2023 JST expanded its service offerings to include technical consulting.

Rionne McAvoy, Director of "The Ones Left Behind" to Appear at The Foreign Correspondents' Club of Japan Press Conference

Retrieved on: 
Wednesday, January 17, 2024
Miyako-jima, World War II, Mother, Foreign Correspondent, JST, The Japan Times, Tokyo Weekender, FCCJ, Best, Single Mother, Poverty, Publication, Film industry

TOKYO, Jan. 17, 2024 /PRNewswire-PRWeb/ -- The Foreign Correspondents' Club of Japan (FCCJ), the preeminent institution for international media in Japan, will host Rionne McAvoy, director of the acclaimed documentary film "The Ones Left Behind: The Plight of Single Mothers in Japan," at a press conference. The event will take place on 23 January 2024 at 11am (JST). FCCJ invites journalists and media. A 10-minute summary of the film will be screened, together with a 10-minute presentation by McAvoy, followed by a 40-minute question and answer session. Questions may be asked both in the room and online.

Key Points: 
  • The Foreign Correspondents' Club of Japan (FCCJ) will host Rionne McAvoy, the director of the acclaimed documentary film 'The Ones Left Behind,' at a press conference on 23 January 2024.
  • TOKYO, Jan. 17, 2024 /PRNewswire-PRWeb/ -- The Foreign Correspondents' Club of Japan (FCCJ), the preeminent institution for international media in Japan, will host Rionne McAvoy, director of the acclaimed documentary film "The Ones Left Behind: The Plight of Single Mothers in Japan," at a press conference.
  • We are immensely grateful to The Foreign Correspondents' Club of Japan of Japan for offering us such a substantive platform."
  • Celebrated by respected publications like Tokyo Weekender and The Japan Times, 'The Ones Left Behind' continues to receive widespread positive reviews.

Netcracker Highlights the Benefits of AI-Driven Digital Transformations for Telcos at TM Forum’s Tokyo Summit

Retrieved on: 
Tuesday, January 16, 2024
Apps, Applications, Mobile, Wireless, Technology, Telecommunications, Software, Audio, Video, Networks, Internet, Data Management, Artificial Intelligence, JST, Digital transformation, NTT, NEC, Netcracker Technology

Netcracker, along with its long-term customer NTT and parent company NEC, will discuss leveraging digital transformation to drive business growth.

Key Points: 
  • Netcracker, along with its long-term customer NTT and parent company NEC, will discuss leveraging digital transformation to drive business growth.
  • AI-driven IT platforms and streamlined processes can expand revenue opportunities, create a greater competitive edge, increase operational effectiveness and accelerate time to market.
  • The panel will highlight recent results and lessons learned from major digital transformation programs.
  • Netcracker is the Headline Sponsor of the event and will exhibit in Booth 2.

Transgene and NEC Extend their Collaboration to Continue Joint Clinical Development of Neoantigen Cancer Vaccine TG4050

Retrieved on: 
Monday, January 8, 2024
Health care, ASCO, Euronext Paris, Cancer, Head, JST, AI, NEC, Patient, Corporation, Vaccine

Based on promising data obtained in the Phase I[*] trial ( NCT04183166 ), Transgene and NEC are preparing a randomized Phase I/II extension of this trial slated to start in 2024.

Key Points: 
  • Based on promising data obtained in the Phase I[*] trial ( NCT04183166 ), Transgene and NEC are preparing a randomized Phase I/II extension of this trial slated to start in 2024.
  • Transgene and NEC expect to present additional immunological and clinical data from the Phase I trial at a scientific conference in the first half of 2024.
  • We are looking forward to continuing to treat patients in our clinical studies with our individualized cancer vaccine TG4050.
  • Our joint clinical development plan builds on these promising data in a setting where there is no approved treatment to prevent patient relapse after adjuvant chemoradiotherapy.

Quantum computer sources majority of components from Japanese makers

Retrieved on: 
Wednesday, December 20, 2023
Software, LTD, Quantum biology, Bed, Education minister, SIP, Nippon Telegraph and Telephone, Associate professor, Culture, Machine learning, MEXT, Quel, Algorithm, Amazon Web Services, Drug discovery, Fujitsu, Team, Communication, Cross, RQC, Superconductivity, AIST, Quantum, NTT, JST, Ministry, Development, NICT, Research, QST, Postgraduate education, Quantum information, Osaka University, Microscope

(SEC) today announced the successful development of Japan's third superconducting quantum computer (1) installed at Osaka University.

Key Points: 
  • (SEC) today announced the successful development of Japan's third superconducting quantum computer (1) installed at Osaka University.
  • For the new quantum computer, the research team sourced more domestically manufactured components (excluding the refrigerator).
  • The research team confirmed that the new quantum computer, including its components, provides sufficient performance and will utilize the computer as a test bed for components made in Japan.
  • JPMXS 0118068682) and "Development of quantum software by intelligent quantum system design and its applications' (Team leader: Keisuke Fujii; Grant No.

DOCOMO to Showcase Diverse Technologies at docomo Open House '24

Retrieved on: 
Wednesday, November 22, 2023
Tokyo International Forum, The Open House, NTT, NTT DOCOMO, JST, AI, Transport, Open House, INC, House, Communication

TOKYO, Nov 22, 2023 - (JCN Newswire) - NTT DOCOMO, INC. announced today that "docomo Open House '24 - Co-creation starts here."

Key Points: 
  • TOKYO, Nov 22, 2023 - (JCN Newswire) - NTT DOCOMO, INC. announced today that "docomo Open House '24 - Co-creation starts here."
  • will take place at the Tokyo International Forum (Hall E1) next January 17 and 18, and the online version of the Open House will be accessible from January 17 until February 29.
  • The Open House will provide visitors with opportunities to learn about the positive impact of DOCOMO's advanced technologies on society as well as DOCOMO's commitment to contributing to society through collaboration with various partners.
  • 31 exhibits will cover a wide range of fields, including technologies for 5G Evolution & 6G, urban design, transportation, communication, generative AI, and metaverse/XR.

JST Manufacturing Formally Introduces Ospray Single-Wafer Wet Processing Family

Retrieved on: 
Tuesday, November 14, 2023
Light-emitting diode, JST, Growth, Indium phosphide, Silicon carbide, Silicon, CS, Laser, Gallium nitride, MEMS, Ospraie Management, LLC

MERIDIAN, Id., Nov. 14, 2023 (GLOBE NEWSWIRE) -- JST Manufacturing, Inc. , a leading provider of wet benches and chemical processing systems for semiconductor manufacturing, today formally introduced its Ospray family of single-wafer wet processing systems.

Key Points: 
  • MERIDIAN, Id., Nov. 14, 2023 (GLOBE NEWSWIRE) -- JST Manufacturing, Inc. , a leading provider of wet benches and chemical processing systems for semiconductor manufacturing, today formally introduced its Ospray family of single-wafer wet processing systems.
  • In production at multiple customer sites, the Ospray tools leverage JST’s extensive expertise in wet chemistries, positioning the company to become a complete supplier of wet processing solutions.
  • For U.S.-based customers, adding Ospray to its wet processing family further positions JST to benefit from heightened focus on domestic growth and onshoring in the U.S. semiconductor industry.
  • To learn more about Ospray and JST Manufacturing’s full line of wet processing solutions, please visit us in booth B2161 at SEMICON Europa, November 14-17, in Munich, Germany.

Daiichi Sankyo Demonstrates Breadth and Depth of Oncology Portfolio Across Multiple Cancers with New Data at ESMO Asia, SABCS and ASH

Retrieved on: 
Friday, December 1, 2023
Research, Genetics, Clinical Trials, Biotechnology, Health, Pharmaceutical, General Health, Science, Oncology, Lung, American Society of Hematology, Breast, Annual general meeting, Bone marrow, Fulvestrant, ASH, Acute myeloid leukemia, JST, ADC, Patient, Anastrozole, Lung cancer, TSE, Daiichi Sankyo, HER2, MD, R, AML, Cancer, Society, PTCL, NSCLC, Pharmaceutical industry

Daiichi Sankyo (TSE: 4568) will present new clinical research across its oncology portfolio in multiple types of solid and blood cancers at the 2023 ESMO Asia Congress (#ESMOAsia23), San Antonio Breast Cancer Symposium (#SABCS23) and American Society of Hematology (#ASH23) Annual Meeting prior to its annual R&D Day.

Key Points: 
  • Daiichi Sankyo (TSE: 4568) will present new clinical research across its oncology portfolio in multiple types of solid and blood cancers at the 2023 ESMO Asia Congress (#ESMOAsia23), San Antonio Breast Cancer Symposium (#SABCS23) and American Society of Hematology (#ASH23) Annual Meeting prior to its annual R&D Day.
  • “Our goal is to push the boundaries of science to change the way cancer is treated,” said Ken Takeshita, MD, Global Head, R&D, Daiichi Sankyo.
  • Daiichi Sankyo will hold its annual R&D Day for investors, analysts and media on Monday, December 11 at 5:30 - 7:00 pm EST/Tuesday, December 12 at 7:30 - 9:00 am JST.
  • Company executives will provide highlights of Daiichi Sankyo’s research data presented at SABCS and ASH, as well as updates on the company’s R&D strategy.